Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 515692, 3 pages
http://dx.doi.org/10.1155/2012/515692
Editorial

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations

1Division of Cardiology, Department of Medical Specialties, Geneva University Hospitals and University of Geneva, Avenue de la Roseraie 64, 1211 Geneva, Switzerland
2First Medical Clinic, Laboratory of Phagocyte Physiopathology and Inflammation, Department of Internal Medicine, University of Genoa, Viale Benedetto XV 6, 16100 Genoa, Italy
3Laboratory of Hypertension, Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil
4Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil, 1211 Genera, Switzerland

Received 1 April 2012; Accepted 1 April 2012

Copyright © 2012 Fabrizio Montecucco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998. View at Google Scholar · View at Scopus
  2. I. Tzoulaki, K. C. Siontis, and J. P. Ioannidis, “Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study,” British Medical Journal, vol. 343, article d6829, 2011. View at Publisher · View at Google Scholar
  3. U. N. Khot, M. B. Khot, C. T. Bajzer et al., “Prevalence of conventional risk factors in patients with coronary heart disease,” Journal of the American Medical Association, vol. 290, no. 7, pp. 898–904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. P. Murphy, R. Dhangana, M. J. Pencina, A. M. Zafar, and R. B. D'Agostino, “Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment,” Atherosclerosis, vol. 216, no. 2, pp. 452–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Nasir, E. D. Michos, R. S. Blumenthal, and P. Raggi, “Detection of high-risk young adults and women by coronary calcium and national cholesterol education program panel III guidelines,” Journal of the American College of Cardiology, vol. 46, no. 10, pp. 1931–1936, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Johnson and D. A. Dowe, “The detection of any coronary calcium outperforms framingham risk score as a first step in screening for coronary atherosclerosis,” American Journal of Roentgenology, vol. 194, no. 5, pp. 1235–1243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I,” Circulation, vol. 108, no. 14, pp. 1664–1672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II,” Circulation, vol. 108, no. 15, pp. 1772–1778, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Mirabelli-Badenier, V. Braunersreuther, G. L. Viviani et al., “CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke,” Journal of Thrombosis and Haemostasis, vol. 105, no. 3, pp. 409–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Guasti, F. Dentali, L. Castiglioni et al., “Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects,” Thrombosis and Haemostasis, vol. 106, no. 4, pp. 591–599, 2011. View at Google Scholar
  11. W. Koenig, “Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein,” International Journal of Cardiology, vol. 98, no. 2, pp. 199–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Montecucco and F. Mach, “New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor,” Clinical Interventions in Aging, vol. 3, no. 2, pp. 341–349, 2008. View at Google Scholar · View at Scopus
  13. F. Montecucco, N. Vuilleumier, S. Pagano et al., “Anti-apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability,” European Heart Journal, vol. 32, no. 4, pp. 412–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Montecucco, A. Pende, and F. MacH, “The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies,” Mediators of Inflammation, vol. 2009, Article ID 752406, 13 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Libby, P. M. Ridker, and G. K. Hansson, “Progress and challenges in translating the biology of atherosclerosis,” Nature, vol. 473, no. 7347, pp. 317–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Wojakowski, U. Landmesser, R. Bachowski, T. Jadczyk, and M. Tendera, “Mobilization of stem and progenitor cells in cardiovascular diseases,” Leukemia, vol. 2012, no. 26, pp. 23–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Montecucco and F. Mach, “Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis,” Rheumatology, vol. 48, no. 1, pp. 11–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Rosenfeld and L. A. Campbell, “Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis,” Journal of Thrombosis and Haemostasis, vol. 106, pp. 858–867, 2011. View at Google Scholar
  19. F. Montecucco, S. Steffens, and F. Mach, “Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability,” Mediators of Inflammation, vol. 2008, Article ID 767623, 10 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus